Ethical Compliance
JAGSONPAL PHARMACEUTICALS
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
small
Revenue
3.9%
Debt
4.1%
Liquidity
68.1%
Revenue
Debt
Liquidity
3.9%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Formulation | ₹202.06 |
| Active Pharmaceutical Ingredients | ₹6.64 |
| Other Income | ₹0.69 |
Questionable
INR Crores
Non Compliant
INR Crores
| Interest income | ₹8.59 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹8.59 |
| Total: | ₹8.59 |
| Total Revenue: | ₹217.98 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹8.59
₹217.98
= 3.9%
questionable
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
